Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0423716 (
Neuropathic pain
)
1,417
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Neuropathic pain
is a common cause of pain after nerve injury, but its molecular basis is poorly understood. In a post-gene chip microarray effort to identify new target genes contributing to neuropathic pain development, we report here the characterization of a novel neuropathic pain contributor,
thrombospondin-4
(
TSP4
), using a neuropathic pain model of spinal nerve ligation injury.
TSP4
is mainly expressed in astrocytes and significantly upregulated in the injury side of dorsal spinal cord that correlates with the development of neuropathic pain states.
TSP4
blockade by intrathecal antibodies, antisense oligodeoxynucleotides, or inactivation of the
TSP4
gene reverses or prevents behavioral hypersensitivities. Intrathecal injection of
TSP4
protein into naive rats is sufficient to enhance the frequency of EPSCs in spinal dorsal horn neurons, suggesting an increased excitatory presynaptic input, and to cause similar behavioral hypersensitivities. Together, these findings support that injury-induced spinal
TSP4
may contribute to spinal presynaptic hypersensitivity and neuropathic pain states. Development of
TSP4
antagonists has the therapeutic potential for target-specific neuropathic pain management.
...
PMID:Thrombospondin-4 contributes to spinal sensitization and neuropathic pain states. 2274 97